Shock, Hemorrhagic: Clinical Trials

79 trials for Shock, Hemorrhagic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed, 13 unknown, 9 terminated, 7 recruiting. 18 Phase 3, 16 Phase 2, 15 Not applicable, 3 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 318Completed 11, Recruiting 2, Withdrawn 2, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 216Completed 7, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 2
Not applicable15Completed 8, Terminated 2, Unknown 2, Withdrawn 2, Recruiting 1
Phase 13Completed 2, Terminated 1
Phase 41Withdrawn 1

Follow Shock, Hemorrhagic: new trials by email Literature Review of Shock, Hemorrhagic trials Research Report on Shock, Hemorrhagic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Predictors of In-Hospital Mortality in Severe Abdominal Trauma
Abdominal Injuries, Wounds and Injuries
RecruitingMinia University4302026-10-012026-10-02
Effect of Resuscitation on Gastric Emptying Using POCUS in Pediatric Trauma Patients
Hemorrhagic Shock, Pediatric Trauma
Not yet recruitingAssiut University502026-10-012026-09-09
Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries.
Crystalloid below 1000 mL., IV fluids more than 1,000 mL - Trauma and Emergency Care, Shock,Hemorrhagic
Not yet recruitingHospital Departamental de Villavicencio7162026-10-012026-05-28
Inferior Vena Cava Versus Subclavian Vein Collapsibility for Predicting Fluid Responsiveness in Trauma Hemorrhagic Shock
Hemorrhagic Shock, Trauma
Not yet recruitingAssiut University1202026-10-012026-09-14
Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage
Pathogen Reduced Cryoprecipitated Fibrinogen Complex - Hypofibrinogenemia, Hemorrhage
Enrolling by invitationCerus Corporation3202026-09-152026-10-14
Hemorrhagic Shock in Orthopedic Fractures
Hemorrhagic Shock, Pelvic Fractures
Not yet recruitingSohag University2502026-07-252026-07-10
Evaluation of Transthoracic Echocardiography Parameters and Their Changes in Blood Donor Volunteers
Transthoracic Echocardiography measurements - Hemorrhage, Trauma
Not applicableCompletedCentre Hospitalier Universitaire de Nīmes662025-10-022026-10-22
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock
low-titer O-group whole blood, 1:1:1 component transfusion, ABO- and Rh-compatible whole blood - Hemorrhage, Hemorrhagic Shock
Phase 3Not yet recruitingXijing Hospital1802025-09-012025-08-19
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
ResQFoam - Hemorrhagic Shock, Trauma
Not applicableRecruitingArsenal Medical, Inc.402025-08-072025-11-10
Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery
Viscoelastometric hemostatic assay - Hemorrhage, Cardiac Surgery
CompletedPitié-Salpêtrière Hospital6002025-07-102026-04-20
Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock
Haemorrhagic Shock, Trauma Coagulopathy
RecruitingMedical University of Graz102025-06-012025-12-17
Empiric Calcium in Massive Transfusion
Calcium Gluconate - Hemorrhage, Trauma
Phase 3WithdrawnUniversity of California, Irvine2025-01-012026-03-30
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Low Titer Group O Whole Blood (LTOWB), Placebo, Tranexamic Acid (TXA) - Hemorrhagic Shock, Trauma Injury
Phase 3RecruitingPhilip Spinella10002024-11-012026-09-17
Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients
Protonix (Pantoprazole) 40 mg q 12 hrs for 2 days, Protonix (pantoprazole) 40 mg q 24 hrs for 2 days - Acute Kidney Injury
Phase 2 / Phase 3RecruitingThe University of Texas Health Science Center, Houston1002024-09-072026-02-19
Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock
Crystalloid and blood as resuscitation, crystalloid, blood and low dose of norepinephrine - Mortality Rate, Hemorrhagic Shock
Not applicableCompletedTanta University602024-08-302025-07-11
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Calcium Gluconate, Vasopressin, saline placebo - Trauma, Hemorrhage
Phase 2RecruitingJason Sperry10502024-06-302026-10-30
Metabolic Reprogramming in Renal Tubular Cells in Acute Kidney Injury Following Severe Trauma
Multi-organ Failure After Severe Trauma
UnknownAssistance Publique - Hôpitaux de Paris802024-06-272024-07-15
Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients
Debridement Surgery, Sdc-1 Level Measurement - Syndecan 1, Severe Burn
RecruitingHospital Universitari Vall d'Hebron Research Institute402024-03-052024-11-01
Norepinephrine in Preperiod of Hypotensive Resuscitation in Hemorrhagic Shock
Low dose of Norepinephrine (NE), High dose of Norepinephrine (NE) - Norepinephrine, Hemorrhagic Shock
Not applicableUnknownTanta University2002023-12-012024-03-15
Efficacy and Safety of Early Use PCC in Severe Trauma
4 factor Prothrombin Complex Concentrates - Severe Trauma, Traumatic Shock
Not applicableCompletedSecond Affiliated Hospital, Zhejiang University, School of Medicine3802023-08-102026-04-20

Showing 20 of 79. Sign in to see all of them.

Narrower conditions

Wounds and Injuries (35)  ·  Hemorrhage (22)  ·  Shock (10)  ·  Hemostatic Disorders (8)  ·  Shock, Traumatic (8)  ·  Multiple Trauma (7)  ·  Accidental Injuries (6)  ·  Brain Injuries, Traumatic (5)  ·  Wounds, Penetrating (4)  ·  Acidosis, Lactic (3)  ·  Sepsis (3)  ·  Shock, Septic (3)  ·  Wounds, Nonpenetrating (3)  ·  Acute Kidney Injury (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (79)  ·  Pathologic Processes (78)  ·  Shock (69)  ·  Hemorrhage (57)  ·  Wounds and Injuries (15)  ·  Cardiovascular Diseases (11)  ·  Vascular Diseases (10)  ·  Hematologic Diseases (9)  ·  Hemic and Lymphatic Diseases (9)  ·  Hemorrhagic Disorders (9)  ·  Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Nervous System Diseases (7)  ·  Infections (6)  ·  Brain Injuries (5)

Interventions

Standard of Care (5)  ·  Saline Solution (4)  ·  Sodium Chloride (4)  ·  Norepinephrine (3)  ·  PEG-hemoglobin (3)  ·  Resuscitation (3)  ·  Ringer's Lactate (3)  ·  Tranexamic Acid (3)  ·  maleimide-polyethylene glycol-modified hemoglobin, MP4 (3)  ·  Blood Specimen Collection (2)  ·  Calcium Gluconate (2)  ·  Erythrocyte Count (2)  ·  Valproic Acid (2)  ·  Vasopressins (2)  ·  polynitroxylated pegylated hemoglobin (2)

Sponsors

Assiut University (4)  ·  Jason Sperry (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Sangart (3)  ·  Dartmouth-Hitchcock Medical Center (2)  ·  Denver Health and Hospital Authority (2)  ·  Dr. Hasan Alam (2)  ·  Haukeland University Hospital (2)  ·  Tanta University (2)  ·  The University of Texas Health Science Center, Houston (2)  ·  University of Alabama at Birmingham (2)  ·  University of California, Irvine (2)  ·  University of California, San Francisco (2)  ·  University of Maryland, Baltimore (2)  ·  University of Washington (2)

Countries

United States (35)  ·  France (12)  ·  Canada (6)  ·  Egypt (5)  ·  Germany (5)  ·  China (4)  ·  Norway (4)  ·  Australia (3)  ·  Austria (3)  ·  New Zealand (3)  ·  South Africa (3)  ·  Spain (3)  ·  Switzerland (3)  ·  United Kingdom (3)  ·  Brazil (2)

Top investigators

Karim Brohi, MD (3)  ·  Hasan Alam, MD (2)  ·  Jan Jansen, MBBS, PhD (2)  ·  Jason Sperry, MD (2)  ·  Amy Goldberg, MD (1)  ·  Bruce D Spiess, MD, FAHA (1)  ·  Charles Van Way, III, M.D. (1)  ·  David Hoyt, MD (1)  ·  David T Neilipovitz, MD (1)  ·  Dongsheng Zhou, MD, PhD (1)

Results publications

PMID 25647203, PMID 26220293, PMID 38531812, PMID 40271704, PMID 17109736, PMID 18090009, PMID 19228496, PMID 21112053, PMID 21115374, PMID 21332727, PMID 21841534, PMID 22071998, PMID 22777113, PMID 23857856, PMID 24088993, PMID 24335442, PMID 24751831, PMID 24940804, PMID 24996573, PMID 25275593, PMID 25782753, PMID 25784523, PMID 25784527, PMID 25816119, PMID 25947955, PMID 26002260, PMID 26376142, PMID 26508436, PMID 26522327, PMID 26680132, PMID 26773077, PMID 28183347, PMID 28374096, PMID 28497259, PMID 28611888, PMID 28731937, PMID 28930959, PMID 29766088, PMID 29793591, PMID 30030268, PMID 30032977, PMID 30447946, PMID 31050809, PMID 31461138, PMID 31851290, PMID 31969168, PMID 32983160, PMID 33797501, PMID 34330462, PMID 34530886

NIH funding

U01HL077863 (2), 1UG3HL157401-01A1 (1), R34HL135224 (1), U24HL157310 (1)